ETEK Chart: The last two candles have formed Bullish Harami
ETEK Chart: The last two candles have formed Bullish Harami Cross reversal pattern……..the chart below shows ETEK has formed Doji's 3 times in the last two weeks…….the first two Doji's gave false reversal signals………the key for Friday's pattern will be a green candle and higher close than Friday's close……that would confirm the pattern……….
One reason why the current pattern may be different from the previous two is the location of the Doji……….on Friday ETEK formed a Doji right at the 200 DMA @ 0.0044 support……..it is not a coincidence that ETEK closed at 0.0045 on Friday…….the 200 day moving average is a Major Support level…….some would argue that it's the grand daddy of them all……..that being said there are very good odds IMO that ETEK bounces next week……….
Take a look at the 2nd chart……….the 100 DMA @ 0.0041 is another Major support level…….the lower wick on Friday's candle hit MA(100) support and ETEK bounced……..Fast Sto & Slow Sto are @ Oversold levels……..RSI is currently in the 30's and is close to the below 30 oversold level……..
Another Indicator signaling a possible bounce are the Bollinger Bands……….Friday's Doji formed mainly below the Lower BB w/ the horizontal line even w/ the Lower BB @ 0.0045……….the wick on Friday's candle is completely below the lower BB……this signals that the current downtrend is unsustainable…………….Also, Accum/Dist & CMF have been rising while the share price has been declining……..the lower wicks on the candles show the loading……….rising volume Indicators and declining share price is another signal bounce players look for when charting……..
http://www.cmsfx.com/en/forex-education/techn...oney-flow/
The Chaikin Money Flow (CMF) indicator was developed by Marc Chaikin to create an oscillating indicator for his earlier, cumulative indicator Accumulation/Distribution. Both indicators measure the degree to which money is flowing into or out of a security or currency. Chaikin created these indicators to expand and improve on an earlier volume indicator, On Balance Volume.
On Balance Volume (OBV) compares a currency pair's closing price with its previous day's close and either adds or subtracts the volume to a cumulative total, if the pair is up or down respectively. Accumulation/Distribution (A/D) altered the parameters of OBV by using the mean price, the midpoint between the periods high and low, to decide whether volume for that period was being accumulated (bought) or distributed (sold). After categorizing the period either as accumulation or distribution A/D then adds or subtracts volume based on the degree to which the pair closed above or below its open. The main difference between Chaikin’s two volume indicators is that Accumulation/Distribution is a cumulative running total while Chaikin Money Flow oscillates around a zero line
MA's(7 & 10) @ 0.0052 & 0.0055 are the 1st levels to break…….when ETEK forms candles above the Middle Bollinger Band / MA(20) @ 0.0060 a new Up trend can begin………..
ETEK on Bullish Reversal Confirmation Radar……………..$$$
http://stockcharts.com/h-sc/ui?s=ETEK&p=D...7336114432
http://stockcharts.com/h-sc/ui?s=ETEK&p=D...0313948788
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...
Continue Reading
Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...
Continue Reading
Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...
Continue Reading
Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...
Continue Reading
Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...
Continue Reading
Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Top 5 Most Recently Viewed Articles
Iceland Seafood International hf's Successful Auction Iceland Seafood International hf. has recently completed an offering of 3-month bills under the new series ICESEA 25 0304. This significant milestone reflects the company's ongoing efforts to strengthen its financial position and enhance its market presence. Details of the Bill Auction The total offers for the bills...
Continue Reading
Prolong Pharmaceuticals Highlights Phase 1 Results for Acute Ischemic Stroke Treatment Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical firm, is making waves in the medical community with its recent announcement regarding the preliminary data from the HEMERA-1 trial. This significant study looks into the effects of their lead asset, PP-007, in treating...
Continue Reading
Investors: Consider Joining the Verve Therapeutics Class Action Robbins LLP, a shareholder-rights law firm, is reminding investors about an important window to act in the class action against Verve Therapeutics, Inc. (NASDAQ: VERV). The lawsuit covers individuals and entities that bought or otherwise acquired Verve securities during a defined time frame. Verve is a...
Continue Reading
Building Passive Income Through Smart Investments Creating passive income is a crucial element of a successful early retirement plan. Establishing various sources of passive income is important to reduce the pressure of depending solely on active work for financial support. A key aspect of this strategy is investing in companies known for their above-average dividends,...
Continue Reading
The temperature monitoring devices market experienced a notable surge back in 2024, with projections estimating a compound annual growth rate (CAGR) of 4.5% through to 2034. By the end of that forecast period, sales revenue was set to hit around USD 5.3 billion—a clear indicator of robust expansion in this critical sector. Market Dynamics: Diverse Applications Across...
Continue Reading